BRIEF-Myovant Sciences And Pfizer Announce First Participant Dosed In Phase 3 Serene Study Evaluating Contraceptive Efficacy Of Once-Daily Relugolix Combination Tablet
BRIEF-Myovant Sciences And Pfizer Announce First Participant Dos:BRIEF-Myovant Sciences And Pfizer Announce First Participant Dosed In Phase 3 Serene Study Evaluating Contraceptive Efficacy Of Once-Daily Relugolix Combination Tablet